Most recently, it has been recognized that conolidine and the above derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts as being a scavenger and will not activate a second